Selecta Biosciences
Watertown · Founded 2008
About Selecta Biosciences
Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Their proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles. It was founded in 2008 and is headquartered in Watertown, Massachusetts.
Company Facts
- Founded: 2008
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $380.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Nov 2023)
- Ticker: nasdaq:SELB
- Website: selectabio.com
- Phone: (617) 923-1400
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/selecta-biosciences-135445 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.